Overview
Thorium Norway AS is leveraging the unique properties of thorium to revolutionize the pharmaceutical industry. Thorium-derived radium is a critical component in cutting-edge cancer treatments, offering new hope for patients worldwide.
Medical Applications of Thorium
- Targeted Alpha Therapy (TAT): Thorium is used in TAT, a form of cancer treatment where a molecule injected into the body targets and destroys cancer cells with an alpha charge.
- Radium Production: Thorium can be converted into radium, which is essential for new forms of cell-targeted cancer treatments.
Research and Development
- Collaboration with Leading Institutions: Thorium Norway AS through partners, collaborates with top research institutions such as the Institute for Energy Technology (IFE) in Norway, the University of Cambridge in the UK, and Westinghouse Electric Company in the USA.
- Ongoing Studies: Research is focused on developing and optimizing thorium-derived radium for medical applications, ensuring high efficancy and safety.
Market Demand
- The demand for radium is rapidly growing due to advancements in cancer treatment. Our TPP factory will produce large quantities of radium to meet this increasing demand.
- The integration of thorium and radium production processes offers significant synergies, making our operations highly efficient and cost-effective.
